Carolina Liquid Chemistries (CLC) has forged an agreement with medical supply manufacturer and distributor Medline Industries to distribute CLC's point-of-care (POC) fentanyl screening test kit to healthcare providers and clinical laboratories across the U.S.
The Fentanyl Urine Detect test kit is the first POC fentanyl screening test to be cleared by the U.S. Food and Drug Administration, CLC noted in a statement. The test, which provides printable results in under six minutes, was designed to be used on CLC's portable RYAN immunofluorescence analyzer.
"This is a great opportunity for Medline to be part of the solution to the drug crisis in America," Nicole Krpan, general manager of Medline's laboratory products division, said in a statement.
"The opioid epidemic, exacerbated by the potency of fentanyl, claims countless lives every day. With its low cutoff and rapid results, this test offers a new weapon in the fight against the effects of fentanyl."
CLC, which has its headquarters in Greensboro, NC, noted that the Fentanyl Urine Detect test provides a preliminary result; to obtain a confirmed analytical result, a more specific chemical method must be used.
